Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in


November 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
18 Nov 2013 - 19 Nov 2013
TATAA Biocenter, Odinsgatan 28, Gothenburg
2 days Hands-on qPCR
More information
Cell Based Assays
18 Nov 2013 - 19 Nov 2013
London, UK
Cell Based Assays
More information
20 Nov 2013 - 20 Nov 2013
TATAA Biocenter, Odinsgatan 28, Gothenburg
1 day Sample preparation and quality control
More information
Outsourcing in Clinical Trials Canada 2013
20 Nov 2013 - 21 Nov 2013
Toronto, Canada
Outsourcing in Clinical Trials Canada 2013
More information
21 Nov 2013 - 22 Nov 2013
TATAA Biocenter, Odinsgatan 28, Gothenburg
2 days Experimental design and data analysis
More information
India Lab Expo
21 Nov 2013 - 23 Nov 2013
Hyderabad, India
India Lab Expo
More information

<< 1 2 >>

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos